Small Compound 6-O-Angeloylplenolin Induces Mitotic Arrest and Exhibits Therapeutic Potentials in Multiple Myeloma

Sesamin Manifests Chemopreventive Effects through the Suppression of NF-κB–Regulated Cell Survival, Proliferation, Invasion, and Angiogenic Gene Products

(2010) Kuzhuvelil B. Harikumar et al.   MOLECULAR CANCER RESEARCH

Bortezomib induces canonical nuclear factor- B activation in multiple myeloma cells

(2009) T. Hideshima et al.   BLOOD

A High Throughput, Whole Cell Screen for Small Molecule Inhibitors of the Mitotic Spindle Checkpoint Identifies OM137, a Novel Aurora Kinase Inhibitor

(2009) Joanna H. DeMoe et al.   CANCER RESEARCH

Two new terpene glucosides and antitumor agents fromCentipeda minima

(2009) Lin-Fen Ding et al.   JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH

Multiple myeloma

(2009) Marc S Raab et al.   LANCET

A Novel Therapeutic Combination Using PD 0332991 and Bortezomib: Study in the 5T33MM Myeloma Model

(2008) E. Menu et al.   CANCER RESEARCH

MZ3 can induce G2/M-phase arrest and apoptosis in human leukemia cells

(2008) Liang Fang et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

6-O-Angeloylenolin induces apoptosis through a mitochondrial/caspase and NF-κB pathway in human leukemia HL60 cells

(2007) Li ChangLong et al.   BIOMEDICINE & PHARMACOTHERAPY